This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.v.. Active years: 2021-2026.
Company Filing History:
1 out of 4,917 
1 out of 165 Years Active: 2021-2026
Title: Sigrun Eick: Innovator in Periodontal Treatment
Introduction
Sigrun Eick is a notable inventor based in Bolligen, Switzerland. She has made significant contributions to the field of dental medicine, particularly in the treatment of periodontal diseases. Her innovative work has led to the development of a patent that addresses critical health issues related to oral infections.
Latest Patents
Sigrun Eick holds a patent for "Bacterial glutaminyl cyclases and inhibitors thereof for use in the treatment of periodontitis." This invention focuses on bacterial glutaminyl cyclases and their inhibitors, which are essential for treating periodontitis and related conditions. The patent provides a bacterial glutaminyl cyclase (bacQC), an antibody that recognizes the bacQC, and methods for identifying inhibitors of the bacQC. Additionally, it includes a pharmaceutical composition comprising a bacQC inhibitor compound, aimed at treating bacterial infections and various forms of periodontal disease.
Career Highlights
Throughout her career, Sigrun Eick has worked with prominent organizations, including the Fraunhofer Society for the Advancement of Applied Research and Ferton Holding S.A. Her experience in these institutions has allowed her to develop her expertise in the field of dental research and innovation.
Collaborations
Sigrun has collaborated with notable colleagues such as Jan Potempa and Nadine Taudte, who have contributed to her research endeavors. Their combined efforts have further advanced the understanding and treatment of periodontal diseases.
Conclusion
Sigrun Eick's contributions to dental medicine through her innovative patent demonstrate her commitment to improving health outcomes for individuals suffering from periodontal diseases. Her work continues to influence the field and offers promising solutions for effective treatment.